CFR /  Title 21  /  Part 99: Dissemination Of Information On Unapproved/New Uses For Marketed Drugs, Biologics, And Devices

Section No.	Description
Section 99.1	Definitions
Section 99.3	Information that may be disseminated
Section 99.101	Mandatory statements and information
Section 99.103	Recipients of information
Section 99.105	Manufacturer's submission to the agency
Section 99.201	Request to extend the time for completing planned studies
Section 99.203	Application for exemption from the requirement to file a supplemental application
Section 99.205	Agency action on a submission
Section 99.301	Extension of time for completing planned studies
Section 99.303	Exemption from the requirement to file a supplemental application
Section 99.305	Corrective actions and cessation of dissemination of information
Section 99.401	Termination of approvals of applications for exemption
Section 99.403	Applicability of labeling, adulteration, and misbranding authority
Section 99.405	Recordkeeping and reports
Section 99.501	Petitions requesting exemption from preemption for State or local requirements